Video Experimental Relacionado
Updated: Jul 12, 2026

03:25
Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
Published on: June 16, 2022
Resumen
La nueva investigación de terapia contra el cáncer involucra a la hexametilena bisacetamida, un medicamento que induce la diferenciación en las células de leucemia de ratón. El trabajo en curso tiene como objetivo reducir los efectos secundarios en pacientes humanos mientras se mantiene la efectividad del medicamento.
Área de la Ciencia:
- Oncología Oncología.
- Farmacología Farmacología.
- La bioquímica es la bioquímica.
Sus antecedentes:
- El fármaco hexametilena bisacetamida ha demostrado potencial para inducir la diferenciación de las células de leucemia de ratón.
- La colaboración entre Sloan-Kettering y la Universidad de Columbia fue clave para este descubrimiento.
Objetivo del estudio:
- Para resaltar el descubrimiento colaborativo del efecto de la hexametilena bisacetamida en las células de la leucemia.
- Informar sobre los esfuerzos en curso para rediseñar el medicamento para mejorar los resultados de los pacientes humanos.
Principales métodos:
- Inducción de la diferenciación en las células de leucemia de ratón mediante el uso de hexametileno bisacetamida.
- Rediseño de fármacos para minimizar los efectos secundarios y preservar la eficacia terapéutica.
Principales resultados:
- La hexametilena bisacetamida induce con éxito la diferenciación en las células de leucemia de ratón.
- La investigación está en marcha para optimizar el medicamento para ensayos en humanos, centrándose en la reducción de los efectos adversos.
Conclusiones:
- La investigación colaborativa sobre la hexametilena bisacetamida representa un paso significativo en el desarrollo de la terapia contra el cáncer.
- Una mayor modificación del fármaco es crucial para una aplicación humana exitosa y segura en el tratamiento del cáncer.
Videos de Conceptos Relacionados
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Alterations in Respiration II
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
Repressible Operon: trp Operon
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
Proofreading
Synthesis of new DNA molecules starts when DNA polymerase links nucleotides together in a sequence that is complementary to the template DNA strand. DNA polymerase has a higher affinity for the correct base to ensure fidelity in DNA replication. The DNA polymerase furthermore proofreads during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.Errors during Replication Are Corrected by the DNA Polymerase EnzymeGenomic DNA is synthesized in...
Proofreading
Synthesis of new DNA molecules starts when DNA polymerase links nucleotides together in a sequence that is complementary to the template DNA strand. DNA polymerase has a higher affinity for the correct base to ensure fidelity in DNA replication. The DNA polymerase furthermore proofreads during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.Errors during Replication Are Corrected by the DNA Polymerase EnzymeGenomic DNA is synthesized in...
Proofreading
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Errors During Replication are Corrected by the DNA Polymerase Enzyme